Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | CA6 | P23280 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | TPMT | P51580 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | PARP1 | P09874 | 2/20 | 0.52 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.52 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.52 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1353136 | 0.89 | CA12 (0.70) | MAPK1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL1353135 | 0.89 | CA1 (0.59) | MAPK1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL11449611 | 0.89 | HDAC1 (0.54) | MAPK1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL20944605 | 0.87 | MAPK1 (0.55) | MAPK1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL29415167 | 0.86 | MAPK1 (0.77) | MAPK1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL335681 | 0.86 | MAPK1 (0.77) | MAPK1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL3787323 | 0.85 | MAPK1 (0.60) | MAPK1CYP1A2CYP3A4CYP2C9TSHR | |
| Hydrochloric Acid SCHEMBL5154533 | 0.84 | MAPK1 (0.74) | MAPK1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL11466941 | 0.83 | GSK3B (0.51) | MAPK1CYP1A2CYP3A4CYP2C9TSHR | |
| SCHEMBL2190365 | 0.82 | ACHE (0.59) | MAPK1CYP1A2CYP3A4CYP2C9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250268903-A1 | RXFP1 AGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2025-08-28 | — | — | US | disclosed |
| CN-101172959-B | N,N*-2[fluoroform (oxygen) group] substituted phenyl derivant of 4-methoxy-1,3-benzene diamide and uses of the same | UNIV TIANJIN TECHNOLOGY | 2010-12-15 | — | — | CN | disclosed |
| CN-101172958-A | N,N*-2(2substituted phenyl) derivant of - 4-methoxy-1,3-benzol diamide and use of the same | UNIV TIANJIN TECHNOLOGY (CN) | 2008-05-07 | — | — | CN | disclosed |
| CN-101172959-A | N,N*-2[fluoroform (oxygen) group] substituted phenyl derivant of 4-methoxy-1,3-benzene diamide and uses of the same | UNIV TIANJIN TECHNOLOGY (CN) | 2008-05-07 | — | — | CN | disclosed |
| US-20050004126-A1 | Method of determining potential allosterically-binding matrix metalloproteinase inhibitors | ANDRIANJARA CHARLES (FR) | 2005-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004126-A1 | Method of determining potential allosterically-binding matrix metalloproteinase inhibitors | MMP13, MMP12, MMP25 | MAPK1 861/4885CYP1A2 3013/4885CYP3A4 1725/4885 |
| US-20250268903-A1 | RXFP1 AGONISTS | RXFP1, RXFP2, RXFP3 | MAPK1 771/4885CYP1A2 1125/4885CYP3A4 3135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.